Canakinumab

Bookmark
  •  
    Subcut
    Canakinumab
    Ilaris 
    • Mechanism of Action
    • A human monoclonal antibody that binds to IL-1β and inhibits its activity, resulting in reduced acute phase response.

Clinical Use

    • Indications
    • Cryopyrin-associated periodic syndromes (CAPS) in adults and children aged 2 years or older
    • Systemic juvenile idiopathic arthritis in patients aged 2 years or older
    • Adverse Effects
    • Injection site reactions
    • Infections
    • Neutropaenia
    • Abdominal pain
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Explore
   
 
Feedback